SET Domain, Bifurcated 2 (SETDB2) Peptide
SETDB2
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits SETDB2
- SETDB2 (SET Domain, Bifurcated 2 (SETDB2))
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-SETDB2 antibody (Catalog #: ARP48955_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- SETDB2 (SET Domain, Bifurcated 2 (SETDB2))
- Synonymes
- C13orf4 Peptide, CLLD8 Peptide, CLLL8 Peptide, KMT1F Peptide, Clld8 Peptide, Gm293 Peptide, SET domain bifurcated 2 Peptide, SET domain, bifurcated 2 Peptide, SETDB2 Peptide, Setdb2 Peptide
- Sujet
-
Proteins that contain a SET domain, such as SETDB2, modulate gene expression epigenetically through histone H3 methylation. SETDB2 is likely a histone H3 methyltransferase, as it contains both the active site and flanking cysteine residues required for catalytic activity.
Alias Symbols: CLLD8, CLLL8, KMT1F, C13orf4
Protein Size: 707 - Poids moléculaire
- 77 kDa
- ID gène
- 83852
- NCBI Accession
- NM_001160308
-
Vous êtes ici:
